Who Owns Orion Health Group Ltd. Company?

Orion Health Group Ltd. Bundle

Get Full Bundle:

	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10
	SWOT	$15	$10

TOTAL:

ADD TO CART

Who owns Orion Health Group Ltd. now?

When Orion Health Group Ltd. delisted from the NZX in 2019, control shifted from public investors to a concentrated private base centered on its founder and strategic backers. The firm, founded in 1993 in Auckland, remains a global health‑IT provider focused on integrating patient data for better clinical decisions.

Ownership today is anchored by founder Ian McCrae alongside strategic investors and employee shareholders, with governance led by a concentrated board reflecting those stakes. See the company product analysis: Orion Health Group Ltd. Porter's Five Forces Analysis

Founders and early ownership of Orion Health Group Ltd centered on Ian J. McCrae, who founded the company in 1993 and served as long-time CEO and principal shareholder; early equity was tightly held among McCrae and a small circle of staff and advisers, with control consistently attributed to him through the 1990s and 2000s.

Founder

Ian J. McCrae is the principal founder and long-time CEO, widely recognised as the controlling shareholder during the company’s formative decades.

Early technical leadership

Key early employees provided technical leadership rather than formal co‑founder status; they received equity through options and grants common in New Zealand tech.

Equity concentration

Throughout the 1990s equity was tightly held by McCrae and a small group of advisers and staff; specific share counts were not publicly disclosed then.

Employee incentives

Orion used early options and ESOP-style grants with typical four-year vesting and one-year cliffs to attract engineers in line with NZ practice.

Angel participation

Growth in the 2000s was largely organic with selective angel investors and retained employee ownership as minority stakes.

Pre‑IPO position

By the 2014 pre‑IPO period McCrae remained the dominant pre‑IPO holder; employees and early backers held smaller, aligned stakes.

Contemporary reports and regulatory filings around the 2014 listing consistently described McCrae as the controlling shareholder; for ownership history and later investor shifts see Growth Strategy of Orion Health Group Ltd.

Key facts

Founders and early ownership snapshot with relevance to 'Who owns Orion Health Group Ltd' and related queries.

• Founder: Ian J. McCrae — principal architect and long‑time CEO.
• Early ownership: tightly held by McCrae and small early team; specific early share counts not publicly disclosed.
• Incentives: ESOP/options with four‑year vesting and one‑year cliff typical in NZ tech.
• Pre‑IPO: McCrae remained dominant pre‑IPO holder; employees/angels held minority stakes aligned with growth strategy.

Orion Health Group Ltd. SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

Key events that reshaped ownership include the November 2014 IPO at NZD 5.70 per share, a 2018 sale of the Rhapsody business for roughly USD 135–150 million, and a 2019 scheme that delisted the company, consolidating control under founder Ian McCrae and aligned private investors.

Post-delisting, the ownership structure shifted from dispersed public shareholders to concentrated private control, enabling multi-year product investment and targeted M&A focused on data interoperability and analytics.

Major stakeholders and influence

Founder Ian McCrae remains the controlling shareholder while a mix of private investors and employee option pools hold the balance. Customer concentration and long-term public-sector contracts now drive strategy more than public market pressures.

• Founder control: Ian McCrae as majority/controlling owner
• Private investors: aligned long-horizon backers post-2019
• Employee ownership: option pools and minority holdings
• Institutional legacy: former public investors reduced after delisting

For detailed revenue and business model context that informs ownership decisions, see Revenue Streams & Business Model of Orion Health Group Ltd.

Orion Health Group Ltd. PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

Orion Health Group Ltd’s board is founder-led, with Ian McCrae acting as executive chair/CEO figurehead and principal representative of the majority shareholder; independent non-executive directors and senior operating executives provide expertise in health informatics, government procurement, cybersecurity and SaaS scaling.

Board seats tied to minority investors are limited; composition prioritises operational continuity with large government and health-system clients and clinical safety oversight.

Board control and voting

Voting uses a standard one-share-one-vote model without a dual-class public structure; control is functionally concentrated because the founder/majority holder maintains >50% influence.

• Board oversight focuses on client assurance, clinical safety and data stewardship
• Committees cover security, privacy and major programme delivery risk
• No public proxy contests or activist campaigns recorded since privatization
• Small number of minority investor seats; emphasis on continuity with government contracts

For background on competitors and market positioning see Competitors Landscape of Orion Health Group Ltd.

Orion Health Group Ltd. Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

Recent developments through 2021–2025 show Orion Health Group Ltd shifting ownership emphasis toward a stable private-shareholder base, reinforcing employee option pools and using contract cash flows to fund platform R&D and regional expansion.

Industry tailwinds—US TEFCA phases go-live 2023–2025, cloud migration, and AI-driven population health analytics—have increased PE and strategic vendor interest; analysts expect consolidation, giving Orion optionality to remain private, pursue tuck-ins, or seek future liquidity if scale or capital needs justify it. See Mission, Vision & Core Values of Orion Health Group Ltd.

Who owns Orion Health Group Ltd

As of 2025 the company remains privately held with a founder-majority stake and refreshed employee option pools to retain senior engineers and delivery leaders.

Orion Health Group ownership structure

Ownership changes since privatization have been limited to incentive grants; no public secondary offerings or control transfers were reported through 2025.

Orion Health major shareholders

Major shareholders are founder(s) and private investors; employee pools target 8–15% fully diluted typical of growth-stage private SaaS peers.

Ownership implications for strategy

Founder-led private ownership supports long-duration government contracts and R&D focus rather than near-term public listing; consolidation pressure from PE and strategic vendors remains a factor.

Orion Health Group Ltd. Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔